Erowid.org: Erowid Reference 653 : 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents : Hekmatpanah CR, Peroutka SJ

Erowid References Database

Hekmatpanah CR, Peroutka SJ. “5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents”. Eur J Pharmacol. 1990;177(1-2):95-8. <a name="ref">Hekmatpanah CR, Peroutka SJ.</a> <a href="/references/653">"5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents"</a> <i>Eur J Pharmacol</i>. 1990;177(1-2):95-8.
Text Abstract (this page) Full Text - English (private) Show Articles by Hekmatpanah CR Peroutka SJ Article IDs Erowid RefID: 653 PubMedID: unknown Collections Hofmann Collection MDMA Collection All References	Abstract This study examined the [3H]5-HT-releasing properties of 3,4-methylenedioxymethamphetamine (MDMA) and related agents, all of which cause significant release of [3H]5-HT from rat brain synaptosomes. 5-HT uptake blockers dose dependently block MDMA-induced [3H]5-HT release. The EC50s of the uptake drugs in blocking MDMA-induced release correlate with their affinity for the 5-HT uptake site labeled by [3H]paroxetine (r = 0.98; P less than 0.01). These data demonstrate that the 5-HT uptake carrier plays a significant role in the release of 5-HT induced by MDMA and related agents.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]